RBI restricts foreign investors from buying in Claris Lifesciences

25 May 2017 Evaluate

The Reserve Bank of India (RBI) has restricted the Foreign Institutional Investors (FIIs)/Foreign Portfolio Investors (FPIs) in Claris Lifesciences as the foreign investors have crossed the overall limit of 24% of paid-up capital of the company.

RBI monitors ceilings on FII/NRI/PIO investments in Indian companies on a daily basis.

Claris Lifesciences is a multi-business enterprise and the holding company of Claris Injectables, a wholly- owned subsidiary dealing in Speciality Injectables business and has a minority stake in Claris Otsuka.


Peers
Company Name CMP
Redington 263.35
Adani Enterprises 2081.05
Amrapali Industries 14.37
Rashi Peripheral 351.00
PDS 296.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×